VENMAX DRUGS & PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Venmax Drugs & Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.62₹ 0.76
As on Dec 1, 2025, 4:01 PM IST
Venmax Drugs & Pharmaceuticals Price Performance
Today's LowToday's High
₹27.59₹30.49
₹29.80
52 Weeks' Low52 Weeks' High
₹0.00₹0.00
₹29.80
Open Price
₹30.49
Prev. Close
₹29.04
Volume
5
Over the last 5 years, the share price of Venmax Drugs & Pharmaceuticals has gained 35.27% CAGR. Over the past year, the corresponding return has been 352.89%.
Venmax Drugs & Pharmaceuticals’s current P/E of 45.29x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Venmax Drugs & Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Venmax Drugs & Pharmaceuticals | 1.53 | 14.31 | -6.55 | 21.04 | 352.89 | 65.45 | 35.27 |
| Sun Pharmaceutical Industries | 1.58 | 5.33 | 13.41 | 6.35 | 1.47 | 19.87 | 27.35 |
| Divi's Laboratories | 0.96 | -1.15 | 5.18 | -2.99 | 4.28 | 24.02 | 12.19 |
| Torrent Pharmaceuticals | 1.25 | 3.78 | 4.98 | 18.03 | 12.30 | 31.78 | 23.01 |
| Cipla | 0.86 | -3.56 | -4.10 | 3.24 | -0.65 | 10.78 | 15.07 |
| Dr. Reddy's Laboratories | 1.24 | 0.59 | -0.24 | 0.96 | 4.79 | 12.26 | 5.47 |
| Lupin | 2.84 | 6.62 | 10.21 | 5.95 | 1.76 | 40.59 | 18.06 |
| Zydus Lifesciences | 1.04 | -6.76 | -4.77 | 1.04 | -3.32 | 32.08 | 15.55 |
| Mankind Pharma | -0.34 | -8.56 | -9.55 | -9.33 | -12.76 | 16.22 | 9.44 |
| Aurobindo Pharma | 0.82 | 9.21 | 18.24 | 3.63 | -3.74 | 37.58 | 6.25 |
| Alkem Laboratories | -1.80 | 1.14 | 5.59 | 5.78 | -0.75 | 21.45 | 14.96 |
| Abbott India | 0.97 | 0.50 | -5.25 | -1.62 | 7.57 | 13.97 | 14.15 |
| Laurus Labs | 5.26 | 7.02 | 20.16 | 67.38 | 81.57 | 36.07 | 26.11 |
| Glenmark Pharmaceuticals | 5.31 | 5.42 | 0.98 | 39.14 | 27.17 | 64.33 | 32.45 |
| Biocon | -0.42 | 5.68 | 13.34 | 17.63 | 8.21 | 11.85 | -1.84 |
| GlaxoSmithKline Pharmaceuticals | -0.08 | -5.57 | -10.37 | -23.69 | 2.00 | 23.33 | 9.96 |
| Anthem Biosciences | 3.89 | -9.22 | -19.39 | -9.66 | -9.66 | -3.33 | -2.01 |
| Ipca Laboratories | -1.17 | 10.75 | 3.33 | -2.85 | -7.55 | 17.83 | 4.63 |
| Ajanta Pharma | 3.02 | 4.03 | 3.28 | -0.59 | -15.44 | 27.59 | 20.16 |
| Gland Pharma | -4.37 | -9.17 | -7.39 | 9.38 | -0.58 | -2.75 | -4.64 |
Over the last one year, Venmax Drugs & Pharmaceuticals has gained 352.89% compared to peers like Sun Pharmaceutical Industries (1.47%), Divi's Laboratories (4.28%), Torrent Pharmaceuticals (12.30%). From a 5 year perspective, Venmax Drugs & Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (27.35%) and Divi's Laboratories (12.19%).
Venmax Drugs & Pharmaceuticals Financials
Venmax Drugs & Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 29.27 | 29.52 |
| 10 | 29.39 | 29.3 |
| 20 | 28.61 | 28.62 |
| 50 | 25.94 | 27.37 |
| 100 | 26.63 | 26.63 |
| 200 | 26.48 | 24.25 |
Venmax Drugs & Pharmaceuticals Share Holding Pattern
In the latest quarter, Venmax Drugs & Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 76.86% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Venmax Drugs & Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 25, 2025, 7:26 PM IST | Venmax Drugs & Pharm - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Nov 25, 2025, 1:15 AM IST | Venmax Drugs & Pharm - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Nov 12, 2025, 9:18 PM IST | Venmax Drugs & Pharm - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025. |
| Nov 12, 2025, 9:09 PM IST | Venmax Drugs & Pharm - Board Meeting Outcome for Outcome Of The Board Meeting |
| Nov 05, 2025, 8:49 PM IST | Venmax Drugs & Pharm - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended Septembe |
About Venmax Drugs & Pharmaceuticals
Venmax Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1988 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1988PLC009102 and registration number is 009102. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.81 Cr. and Equity Capital is Rs. 5.24 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSy.No.115, Brig Sayeed Road, Hanumanji Colony, Bowenpally Picket, Hyderabad Telangana 500009
- Contact
Management
- Mr. Venkata Rao SadhanalaWhole Time Director
- Mrs. Dakshita JainAddnl.Non Exe.Independent Director
- Mr. Reddeppa GundluruNon Exe.Non Ind.Director
- Mr. Swapneshwar MishraNon Exe.Non Ind.Director
- Mr. Dasi Reddy RakeshNon Exe.Non Ind.Director
FAQs on Venmax Drugs & Pharmaceuticals Share Price
What is the share price of Venmax Drugs & Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Venmax Drugs & Pharmaceuticals is ₹29.80 as on Dec 01, 2025.
What kind of stock is Venmax Drugs & Pharmaceuticals?
The Venmax Drugs & Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Venmax Drugs & Pharmaceuticals?
The market cap of Venmax Drugs & Pharmaceuticals is ₹15.61 Cr as on Dec 01, 2025.
What are today's High and Low prices of Venmax Drugs & Pharmaceuticals?
Today’s highest and lowest price of Venmax Drugs & Pharmaceuticals are ₹30.49 and ₹27.59.
What are the 52 Week High and 52 Week Low of Venmax Drugs & Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Venmax Drugs & Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Venmax Drugs & Pharmaceuticals is ₹0.00 and 52-week low of Venmax Drugs & Pharmaceuticals is ₹0.00 as on Dec 01, 2025.
How has the Venmax Drugs & Pharmaceuticals performed historically in terms of returns?
The Venmax Drugs & Pharmaceuticals has shown returns of 2.62% over the past day, 14.31% for the past month, -6.55% over 3 months, 352.89% over 1 year, 65.45% across 3 years, and 35.27% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Venmax Drugs & Pharmaceuticals?
P/E ratio of and PB ratio of Venmax Drugs & Pharmaceuticals are 45.29 and -23.64 on Dec 01, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse